Irradiation at Ultra-High (FLASH) Dose Rates Reduces Acute Normal Tissue Toxicity in the Mouse Gastrointestinal System

Preclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV) irradiation, although this finding is not universal. We investigated the effect of temporal pulse structure and average dose rate of FLASH c...

Full description

Saved in:
Bibliographic Details
Published in:International journal of radiation oncology, biology, physics Vol. 111; no. 5; p. 1250
Main Authors: Ruan, Jia-Ling, Lee, Carl, Wouters, Shari, Tullis, Iain D C, Verslegers, Mieke, Mysara, Mohamed, Then, Chee Kin, Smart, Sean C, Hill, Mark A, Muschel, Ruth J, Giaccia, Amato J, Vojnovic, Borivoj, Kiltie, Anne E, Petersson, Kristoffer
Format: Journal Article
Language:English
Published: United States 01.12.2021
Subjects:
ISSN:1879-355X, 1879-355X
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Preclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV) irradiation, although this finding is not universal. We investigated the effect of temporal pulse structure and average dose rate of FLASH compared with CONV irradiation on acute intestinal toxicity. Whole abdomens of C3H mice were irradiated with a single fraction to various doses, using a 6 MeV electron linear accelerator with single pulse FLASH (dose rate = 2-6 × 10 Gy/s) or conventional (CONV; 0.25 Gy/s) irradiation. At 3.75 days postirradiation, fresh feces were collected for 16S rRNA sequencing to assess changes in the gut microbiota. A Swiss roll-based crypt assay was used to quantify acute damage to the intestinal crypts to determine how tissue toxicity was affected by the different temporal pulse structures of FLASH delivery. We found statistically significant improvements in crypt survival for mice irradiated with FLASH at doses between 7.5 and 12.5 Gy, with a dose modifying factor of 1.1 for FLASH (7.5 Gy, P < .01; 10 Gy, P < .05; 12.5 Gy, P < .01). This sparing effect was lost when the delivery time was increased, either by increasing the number of irradiation pulses or by prolonging the time between 2 successive pulses. Sparing was observed for average dose rates of ≥280 Gy/s. Fecal microbiome analysis showed that FLASH irradiation caused fewer changes to the microbiota than CONV irradiation. This study demonstrates that FLASH irradiation can spare mouse small intestinal crypts and reduce changes in gut microbiome composition compared with CONV irradiation. The higher the average dose rate, the larger the FLASH effect, which is also influenced by temporal pulse structure of the delivery.
AbstractList Preclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV) irradiation, although this finding is not universal. We investigated the effect of temporal pulse structure and average dose rate of FLASH compared with CONV irradiation on acute intestinal toxicity.PURPOSEPreclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV) irradiation, although this finding is not universal. We investigated the effect of temporal pulse structure and average dose rate of FLASH compared with CONV irradiation on acute intestinal toxicity.Whole abdomens of C3H mice were irradiated with a single fraction to various doses, using a 6 MeV electron linear accelerator with single pulse FLASH (dose rate = 2-6 × 106 Gy/s) or conventional (CONV; 0.25 Gy/s) irradiation. At 3.75 days postirradiation, fresh feces were collected for 16S rRNA sequencing to assess changes in the gut microbiota. A Swiss roll-based crypt assay was used to quantify acute damage to the intestinal crypts to determine how tissue toxicity was affected by the different temporal pulse structures of FLASH delivery.MATERIALS AND METHODSWhole abdomens of C3H mice were irradiated with a single fraction to various doses, using a 6 MeV electron linear accelerator with single pulse FLASH (dose rate = 2-6 × 106 Gy/s) or conventional (CONV; 0.25 Gy/s) irradiation. At 3.75 days postirradiation, fresh feces were collected for 16S rRNA sequencing to assess changes in the gut microbiota. A Swiss roll-based crypt assay was used to quantify acute damage to the intestinal crypts to determine how tissue toxicity was affected by the different temporal pulse structures of FLASH delivery.We found statistically significant improvements in crypt survival for mice irradiated with FLASH at doses between 7.5 and 12.5 Gy, with a dose modifying factor of 1.1 for FLASH (7.5 Gy, P < .01; 10 Gy, P < .05; 12.5 Gy, P < .01). This sparing effect was lost when the delivery time was increased, either by increasing the number of irradiation pulses or by prolonging the time between 2 successive pulses. Sparing was observed for average dose rates of ≥280 Gy/s. Fecal microbiome analysis showed that FLASH irradiation caused fewer changes to the microbiota than CONV irradiation.RESULTSWe found statistically significant improvements in crypt survival for mice irradiated with FLASH at doses between 7.5 and 12.5 Gy, with a dose modifying factor of 1.1 for FLASH (7.5 Gy, P < .01; 10 Gy, P < .05; 12.5 Gy, P < .01). This sparing effect was lost when the delivery time was increased, either by increasing the number of irradiation pulses or by prolonging the time between 2 successive pulses. Sparing was observed for average dose rates of ≥280 Gy/s. Fecal microbiome analysis showed that FLASH irradiation caused fewer changes to the microbiota than CONV irradiation.This study demonstrates that FLASH irradiation can spare mouse small intestinal crypts and reduce changes in gut microbiome composition compared with CONV irradiation. The higher the average dose rate, the larger the FLASH effect, which is also influenced by temporal pulse structure of the delivery.CONCLUSIONSThis study demonstrates that FLASH irradiation can spare mouse small intestinal crypts and reduce changes in gut microbiome composition compared with CONV irradiation. The higher the average dose rate, the larger the FLASH effect, which is also influenced by temporal pulse structure of the delivery.
Preclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV) irradiation, although this finding is not universal. We investigated the effect of temporal pulse structure and average dose rate of FLASH compared with CONV irradiation on acute intestinal toxicity. Whole abdomens of C3H mice were irradiated with a single fraction to various doses, using a 6 MeV electron linear accelerator with single pulse FLASH (dose rate = 2-6 × 10 Gy/s) or conventional (CONV; 0.25 Gy/s) irradiation. At 3.75 days postirradiation, fresh feces were collected for 16S rRNA sequencing to assess changes in the gut microbiota. A Swiss roll-based crypt assay was used to quantify acute damage to the intestinal crypts to determine how tissue toxicity was affected by the different temporal pulse structures of FLASH delivery. We found statistically significant improvements in crypt survival for mice irradiated with FLASH at doses between 7.5 and 12.5 Gy, with a dose modifying factor of 1.1 for FLASH (7.5 Gy, P < .01; 10 Gy, P < .05; 12.5 Gy, P < .01). This sparing effect was lost when the delivery time was increased, either by increasing the number of irradiation pulses or by prolonging the time between 2 successive pulses. Sparing was observed for average dose rates of ≥280 Gy/s. Fecal microbiome analysis showed that FLASH irradiation caused fewer changes to the microbiota than CONV irradiation. This study demonstrates that FLASH irradiation can spare mouse small intestinal crypts and reduce changes in gut microbiome composition compared with CONV irradiation. The higher the average dose rate, the larger the FLASH effect, which is also influenced by temporal pulse structure of the delivery.
Author Petersson, Kristoffer
Smart, Sean C
Giaccia, Amato J
Hill, Mark A
Wouters, Shari
Lee, Carl
Verslegers, Mieke
Kiltie, Anne E
Mysara, Mohamed
Ruan, Jia-Ling
Muschel, Ruth J
Vojnovic, Borivoj
Tullis, Iain D C
Then, Chee Kin
Author_xml – sequence: 1
  givenname: Jia-Ling
  surname: Ruan
  fullname: Ruan, Jia-Ling
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 2
  givenname: Carl
  surname: Lee
  fullname: Lee, Carl
  organization: Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom
– sequence: 3
  givenname: Shari
  surname: Wouters
  fullname: Wouters, Shari
  organization: Interdisciplinary Biosciences Group, Belgian Nuclear Research Center (SCK CEN), Mol, Belgium; Molecular Pathology Group, Cell Biology and Histology and Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Campus Drie Eiken, University of Antwerp, Antwerp, Belgium
– sequence: 4
  givenname: Iain D C
  surname: Tullis
  fullname: Tullis, Iain D C
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 5
  givenname: Mieke
  surname: Verslegers
  fullname: Verslegers, Mieke
  organization: Interdisciplinary Biosciences Group, Belgian Nuclear Research Center (SCK CEN), Mol, Belgium
– sequence: 6
  givenname: Mohamed
  surname: Mysara
  fullname: Mysara, Mohamed
  organization: Interdisciplinary Biosciences Group, Belgian Nuclear Research Center (SCK CEN), Mol, Belgium
– sequence: 7
  givenname: Chee Kin
  surname: Then
  fullname: Then, Chee Kin
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 8
  givenname: Sean C
  surname: Smart
  fullname: Smart, Sean C
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 9
  givenname: Mark A
  surname: Hill
  fullname: Hill, Mark A
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 10
  givenname: Ruth J
  surname: Muschel
  fullname: Muschel, Ruth J
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 11
  givenname: Amato J
  surname: Giaccia
  fullname: Giaccia, Amato J
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 12
  givenname: Borivoj
  surname: Vojnovic
  fullname: Vojnovic, Borivoj
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 13
  givenname: Anne E
  surname: Kiltie
  fullname: Kiltie, Anne E
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom
– sequence: 14
  givenname: Kristoffer
  surname: Petersson
  fullname: Petersson, Kristoffer
  email: kristoffer.petersson@oncology.ox.ac.uk
  organization: MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, United Kingdom; Radiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden. Electronic address: kristoffer.petersson@oncology.ox.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34400268$$D View this record in MEDLINE/PubMed
BookMark eNpNkF1LwzAYhYMo7kP_gUgu50Vr0qZJezmm-4CpsA_wbrxNU5fRNjNJxf17C07w5pxz8ZyXwztAl41pFEJ3lISUUP54CPXBmvwYRiSiIUlDQtgF6tNUZEGcJO-X_3IPDZw7EEIoFewa9WLGCIl42kdfC2uh0OC1aTB4vK28hWCuP_Z4NF2O1_MH_GScwivwyuGVKlrZ-Vi2XuFXY2uo8EY71yq8Md9aan_CusF-r_CLabveDJy3Rjdd2-umo9cn51V9g65KqJy6PfsQbafPm8k8WL7NFpPxMpAJY77THGIQmcgly3iZ8EKmCU8lKySDPCMyo6VQIiElgCKpygUQoVicyzJnnEE0RKPfu0drPttuw67WTqqqgkZ1-3ZRwqMo5rGgHXp_Rtu8VsXuaHUN9rT7-1X0A0mNcJQ
CitedBy_id crossref_primary_10_1016_j_ijrobp_2022_05_038
crossref_primary_10_3389_fonc_2025_1550264
crossref_primary_10_1038_s41571_025_01052_8
crossref_primary_10_3390_cancers15082269
crossref_primary_10_1016_j_ijrobp_2024_04_071
crossref_primary_10_1667_RADE_23_00222_1
crossref_primary_10_1016_j_ctro_2024_100860
crossref_primary_10_3390_biom12101376
crossref_primary_10_1016_j_canlet_2024_216651
crossref_primary_10_1016_j_radonc_2025_110744
crossref_primary_10_1007_s41365_024_01523_0
crossref_primary_10_1134_S0006350924700830
crossref_primary_10_1016_j_ijrobp_2023_05_045
crossref_primary_10_1016_j_ctro_2022_11_005
crossref_primary_10_1016_j_ejmp_2025_105014
crossref_primary_10_1016_j_heliyon_2024_e40298
crossref_primary_10_1016_j_ijrobp_2024_02_050
crossref_primary_10_1002_advs_202501797
crossref_primary_10_1002_mp_17876
crossref_primary_10_1038_s41419_025_07988_0
crossref_primary_10_1016_j_radonc_2024_110177
crossref_primary_10_1002_acm2_13790
crossref_primary_10_3389_fonc_2022_995612
crossref_primary_10_3389_fonc_2024_1373453
crossref_primary_10_3389_fonc_2024_1442627
crossref_primary_10_1016_j_radonc_2022_08_009
crossref_primary_10_1016_j_radonc_2024_110576
crossref_primary_10_1016_j_ejmp_2023_102637
crossref_primary_10_1038_s41571_022_00697_z
crossref_primary_10_1360_TB_2024_0838
crossref_primary_10_1186_s10020_025_01135_3
crossref_primary_10_1038_s41598_023_46873_8
crossref_primary_10_1667_RADE_23_00221_1
crossref_primary_10_1016_j_ijrobp_2024_11_092
crossref_primary_10_3390_cells12202435
crossref_primary_10_1088_1361_6560_ada51a
crossref_primary_10_3389_fphy_2023_1185237
crossref_primary_10_3390_ijms25052546
crossref_primary_10_1088_1361_6560_acdc7d
crossref_primary_10_1667_RADE_22_00093_1
crossref_primary_10_1017_erm_2022_5
crossref_primary_10_3389_fonc_2025_1669228
crossref_primary_10_1002_pro6_70001
crossref_primary_10_1088_1361_6560_ade223
crossref_primary_10_3390_ijms232012109
crossref_primary_10_1002_mp_17893
crossref_primary_10_1088_1361_6560_ae0239
crossref_primary_10_3389_fonc_2025_1431700
crossref_primary_10_1016_j_ijrobp_2025_03_047
crossref_primary_10_1093_intbio_zyad013
crossref_primary_10_4329_wjr_v17_i4_105722
crossref_primary_10_1016_j_tranon_2024_102183
crossref_primary_10_1016_j_ijrobp_2025_07_1429
crossref_primary_10_3390_ijms25137157
crossref_primary_10_1016_j_radonc_2024_110197
crossref_primary_10_1016_j_semradonc_2024_04_008
crossref_primary_10_1016_j_hoc_2024_11_008
crossref_primary_10_1016_j_radonc_2023_109953
crossref_primary_10_1016_j_radonc_2022_07_011
crossref_primary_10_1158_1078_0432_CCR_22_1255
crossref_primary_10_7759_cureus_46928
crossref_primary_10_1016_j_radonc_2025_110942
crossref_primary_10_1016_j_ijrobp_2023_12_032
crossref_primary_10_3390_ijms252312506
crossref_primary_10_1016_j_ijrobp_2024_09_006
crossref_primary_10_1016_j_ijrobp_2025_04_021
crossref_primary_10_1093_jrr_rrae079
crossref_primary_10_3389_fimmu_2023_1128774
crossref_primary_10_1016_j_ijrobp_2024_02_015
crossref_primary_10_1016_j_radonc_2022_05_014
crossref_primary_10_1016_j_radonc_2025_111125
crossref_primary_10_1016_j_radonc_2025_111126
crossref_primary_10_1016_j_ijrobp_2023_04_018
crossref_primary_10_3389_fonc_2023_1244488
crossref_primary_10_3389_fonc_2024_1420337
crossref_primary_10_1103_PhysRevAccelBeams_27_044402
crossref_primary_10_3389_fonc_2023_1256760
crossref_primary_10_1080_09553002_2021_2004328
crossref_primary_10_1002_mp_15680
crossref_primary_10_1016_j_ejmp_2022_10_026
crossref_primary_10_1016_j_ijrobp_2024_10_009
crossref_primary_10_1016_j_radonc_2022_05_025
crossref_primary_10_1016_j_ijrobp_2025_01_006
crossref_primary_10_1016_j_ijrobp_2025_01_007
crossref_primary_10_1158_1078_0432_CCR_22_0262
crossref_primary_10_3389_fonc_2024_1369065
crossref_primary_10_1186_s10020_024_01053_w
crossref_primary_10_1088_1361_6560_ad247d
crossref_primary_10_1016_j_ijrobp_2022_11_018
crossref_primary_10_1259_bjr_20211150
crossref_primary_10_1088_1361_6560_ac5de8
crossref_primary_10_1038_s41567_022_01520_3
crossref_primary_10_1016_j_radonc_2021_11_004
crossref_primary_10_1007_s11033_023_08579_y
crossref_primary_10_1016_j_canlet_2025_217895
crossref_primary_10_1088_1361_6560_ad3e5e
crossref_primary_10_3390_ijms241512497
crossref_primary_10_1073_pnas_2208506119
ContentType Journal Article
Copyright Copyright © 2021 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ijrobp.2021.08.004
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
ExternalDocumentID 34400268
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Cancer Research UK
  grantid: C6078/A28736
– fundername: Cancer Research UK
  grantid: 28736
– fundername: Medical Research Council
  grantid: MC_UU_00001/9
– fundername: Cancer Research UK
  grantid: 23279
– fundername: Medical Research Council
  grantid: MC_UU_00001/8
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
1RT
1~5
4.4
457
4G.
53G
5RE
7-5
AAEDT
AAEDW
AALRI
AAWTL
AAXUO
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
AENEX
AEVXI
AFCTW
AFRHN
AFTJW
AGCQF
AHHHB
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
CGR
CUY
CVF
DU5
EBS
ECM
EFKBS
EIF
F5P
FDB
GBLVA
HED
HMO
IHE
J1W
KOM
LX3
M41
MO0
NPM
O9-
OC~
OO-
RNS
ROL
RPZ
SDG
SEL
SES
SSZ
UV1
XH2
Z5R
~S-
7X8
ID FETCH-LOGICAL-c544t-c5ba3a797bc496f56dc8568c4dc4ab90c91f7e750faae08eb7a07e43bcfb464a2
IEDL.DBID 7X8
ISICitedReferencesCount 110
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000720934200033&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1879-355X
IngestDate Thu Oct 02 14:25:15 EDT 2025
Mon Jul 21 06:03:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2021 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c544t-c5ba3a797bc496f56dc8568c4dc4ab90c91f7e750faae08eb7a07e43bcfb464a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/7612009
PMID 34400268
PQID 2562236371
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2562236371
pubmed_primary_34400268
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2021
SSID ssj0001174
Score 2.647408
Snippet Preclinical studies using ultra-high dose rate (FLASH) irradiation have demonstrated reduced normal tissue toxicity compared with conventional dose rate (CONV)...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1250
SubjectTerms Animals
Gastrointestinal Tract
Mice
Mice, Inbred C3H
Particle Accelerators
Radiotherapy Dosage
RNA, Ribosomal, 16S
Title Irradiation at Ultra-High (FLASH) Dose Rates Reduces Acute Normal Tissue Toxicity in the Mouse Gastrointestinal System
URI https://www.ncbi.nlm.nih.gov/pubmed/34400268
https://www.proquest.com/docview/2562236371
Volume 111
WOSCitedRecordID wos000720934200033&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF58IV58P-qLFTzoIZg022z2JEWtCraIVuitzG52oVISTWPRf-9MkuJJELxsThuGncnMNzuTbxg7BRUmIpEtrwkBJihOOU8J4TwAhfakpS-gGjYhe714MFCP9YXbpG6rnPnE0lEnmaE78gsMzRjJolAGl2_vHk2NoupqPUJjni2GCGXIquXghy08qFiYaaC2h3F1MPt1ruzvGr3mmSbGymZF4lmOavsFZJbBprP2XzHX2WoNM3m7sosNNmfTTbbcrQvpW2x6n-fESkBq4VDwl3GRg0dNH_ys89B-vjvn19nE8ieCovyJ-F3x2TYfheU9grlj3i9VxvvZJ76z-OKjlCOY5N3sA_fdwqTIM-KiQBdCklTM6NvspXPTv7rz6hEMnmkJUeCqIQSppDZCRa4VJSZuRbERiRGglW9U4KRF1OEArB9bLcGXVoTaOC0iAc0dtpBmqd1jPMRMUSfaRtbXiBoAwPguBhkY1_SdUg12MjvRIZo41S0gtSjz8OdMG2y3UsvwreLiGIZCUBoZ7_9h9wFbIW1XzSiHbNHhB26P2JKZFqNJflzaDq69x-43e-DPwQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Irradiation+at+Ultra-High+%28FLASH%29+Dose+Rates+Reduces+Acute+Normal+Tissue+Toxicity+in+the+Mouse+Gastrointestinal+System&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Ruan%2C+Jia-Ling&rft.au=Lee%2C+Carl&rft.au=Wouters%2C+Shari&rft.au=Tullis%2C+Iain+D+C&rft.date=2021-12-01&rft.issn=1879-355X&rft.eissn=1879-355X&rft.volume=111&rft.issue=5&rft.spage=1250&rft_id=info:doi/10.1016%2Fj.ijrobp.2021.08.004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1879-355X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1879-355X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1879-355X&client=summon